APAC Active Implantable Medical Devices Market to grow with a growth rate of 8.45% during 2016 to 2021
Browse
Market data tables and in-depth TOC of the Asia Pacific Active Implantable
Medical Devices Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-active-implantable-medical-devices-market-5033/
The Active Implantable Medical Device (AIMD)
Directive 90/385/EEC defines an active implantable medical device as "any
active medical device which is intended to be totally or partially introduced,
surgically or medically, into the human body or by medical intervention into a
natural orifice, and which is intended to remain after the procedure". As
one of the highest risk categories of device, they are subject to severe
regulatory controls both pre- and post-market. The regulatory controls set out
in the AIMD Directive also apply to any accessories that are used to enable the
device to operate as intended, for examples leads, programmers, controllers,
battery packs, software applications, implant kits and refill kits.
Free
sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-active-implantable-medical-devices-market-5033/request-sample
The fragmented healthcare industry and high
operating margins in emerging economies make them attractive to investors when
compared to developed economies. The countries such as China and India have
large population base and the healthcare infrastructure in these countries is
improving, thus illustrating immense healthcare market potential. Manufacturing
medical devices products in the developing regions tend to decrease the overall
cost of manufacturing, thus reducing the cost of the product without altering
the quality. With the increasing income level and the increasing compliance for
high quality implants, the demand for active implantable medical devices is
expected to increase in these countries. The demand for active implantable
medical devices is increasing due to increasing prevalence of cardiovascular
diseases and increasing incidences of neurological disorders. Cardiovascular
disease is the leading cause of premature death around the world. Implantable
cardioverter defibrillators and implantable cardiac pacemakers are the key
medical devices used for the treatment of different cardiovascular conditions.
High prevalence of cardiovascular diseases depicts increased demand for these
devices.
Avail discount @ http://www.marketdataforecast.com/market-reports/asia-pacific-active-implantable-medical-devices-market-5033/request-discount
The Asia-Pacific market for Active
Implantable Medical Devices market is segmented into Product and Region. On the
basis of Product, it is segmented into Implantable Cardioverter Defibrillators
(Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device,
Neurostimulator and Implantable Hearing Devices. Cardioverter defibrillators
held the largest share in the active implantable medical devices market.
Transvenous implantable cardioverter defibrillator is further segmented into
biventricular implantable cardioverter defibrillators, dual-chamber implantable
cardioverter defibrillators. Single-chamber implantable cardioverter
defibrillators accounted for the largest share in this market segment followed
by subcutaneous implantable cardioverter defibrillators. The neurostimulators
market is projected to witness the highest growth rate in this market segment.
Asia Pacific Active
Implantable Medical Devices Market Geographical Analysis
·
China
·
India
·
Japan
·
South Korea
·
Australia
The market in the Asia-Pacific region is
expected to grow at the highest CAGR, due to the rise in geriatric population,
growth in the occurrence of chronic diseases, rise in healthcare spending,
healthcare reforms for infrastructural development, growth in the demand for
advanced technologies to develop advanced products, and less strict
regulations. The disjointed healthcare industry and high operating margins in
developing economies make them attractive to investors as compared to developed
economies. The countries such as China and India have large geriatric
population and the healthcare infrastructure in these countries is improving,
thus illustrating immense healthcare market potential.
Avail
discount @ https://www.marketdataforecast.com/market-reports/asia-pacific-active-implantable-medical-devices-market-5033/request-discount
Asia
Pacific Active Implantable Medical Devices Market Leaders'
Analysis
·
Medtronic
plc
·
Abbott
Laboratories
·
Boston Scientific Corporation
·
BIOTRONIK SE & Co.
KG
·
LivaNova
PLC.
·
Cochlear
Limited
·
MED-EL
·
Sonova Holding
AG
·
William Demant Holding A/S
·
Nurotron Biotechnology Co. Ltd.
Inquire
before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-active-implantable-medical-devices-market-5033/inquire
About Us:
Market Data Forecast is a firm working in the
area of market research and business intelligence. With rich experience in
research across various business domains, we cater to the needs of both
individual and corporate clients. Our analyst team comprises expert
professionals in market research, who with their collective knowledge and
skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International
Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
View latest Press Releases
of MDF @ http://www.marketdataforecast.com/press-releases
Comments
Post a Comment